Glenmede Trust’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2622 |
|
|
2020
Q2 | – | Sell |
-10
| Closed | -$1K | – | 2673 |
|
|
2020
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 2964 |
|
|
2019
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 2964 |
|
|
2019
Q3 | $2 | Sell |
10
-1,186
| -99% | -$237 | ﹤0.01% | 2880 |
|
|
2019
Q2 | $1.1K | Buy |
1,196
+3
| +0.3% | +$3 | ﹤0.01% | 728 |
|
|
2019
Q1 | $1.9K | Buy |
1,193
+2
| +0.2% | +$3 | 0.01% | 639 |
|
|
2018
Q4 | $2.23K | Hold |
1,191
| – | – | 0.01% | 602 |
|
|
2018
Q3 | $2.81M | Hold |
1,191
| – | – | 0.01% | 580 |
|
|
2018
Q2 | $4.1M | Buy |
1,191
+5
| +0.4% | +$17.2K | 0.02% | 495 |
|
|
2018
Q1 | $3.05M | Hold |
1,186
| – | – | 0.01% | 580 |
|
|
2017
Q4 | $3.05M | Sell |
1,186
-1
| -0.1% | -$2.57K | 0.01% | 580 |
|
|
2017
Q3 | $3.37M | Buy |
1,187
+674
| +131% | +$1.91M | 0.01% | 552 |
|
|
2017
Q2 | $1.29M | Hold |
513
| – | – | 0.01% | 726 |
|
|
2017
Q1 | $1.29M | Buy |
513
+2
| +0.4% | +$5.03K | 0.01% | 726 |
|
|
2016
Q4 | $1.15M | Sell |
511
-95
| -16% | -$214K | 0.01% | 723 |
|
|
2016
Q3 | $1.52M | Sell |
606
-80
| -12% | -$200K | 0.01% | 680 |
|
|
2016
Q2 | $2.1M | Buy |
686
+278
| +68% | +$850K | 0.01% | 608 |
|
|
2016
Q1 | $1.3M | Buy |
408
+1
| +0.2% | +$3.17K | 0.01% | 687 |
|
|
2015
Q4 | $2.09M | Sell |
407
-103
| -20% | -$529K | 0.01% | 596 |
|
|
2015
Q3 | $1.62M | Buy |
510
+228
| +81% | +$726K | 0.01% | 636 |
|
|
2015
Q2 | $1.13M | Hold |
282
| – | – | 0.01% | 725 |
|
|
2015
Q1 | $1.12M | Hold |
282
| – | – | 0.01% | 742 |
|
|
2014
Q4 | $1.38M | Hold |
282
| – | – | 0.01% | 646 |
|
|
2014
Q3 | $1.14M | Buy |
+282
| New | +$1.14M | 0.01% | 653 |
|